Role of spinal opioid receptor on the antiallodynic effect of intrathecal nociceptin in neuropathic rat

Neuroscience Letters

Volumn 542, Issue , 2013, Pages 118-122

  Ju, Jin ^a   Shin, Dong Jin ^a   Na, Yoon Chan ^a   Yoon, Myung Ha ^a,b  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Antiallodynia; Neuropathic pain; Nociceptin; Opioid receptor types; Spinal cord

Indexed keywords

KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; NOCICEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL NERVE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; HYPERALGESIA; INFUSIONS, SPINAL; MALE; MOTOR ACTIVITY; NEURALGIA; OPIOID PEPTIDES; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SPINAL CORD; TOUCH;

EID: 84876731897     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.03.026     Document Type: Article

References (33)

1. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 1994, 53:55-63.
2. Coderre T.J. Contribution of protein kinase C to central sensitization and persistent pain following tissue injury. Neurosci. Lett. 1992, 140:181-184.
3. Courteix C., Coudoré-Civiale M.A., Privat A.M., Pélissier T., Eschalier A., Fialip J. Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain. Pain 2004, 110:236-245.
4. Finnerup N.B., Sindrup S.H., Jensen T.S. Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam. Clin. Pharmacol. 2007, 21:129-136.
5. Furst S. Transmitters involved in antinociception in the spinal cord. Brain Res. Bull. 1999, 48:129-141.
6. Hao J.X., Xu I.S., Wiesenfeld-Hallin Z., Xu X.J. Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain 1998, 76:385-393.
7. Hawes B., Graziano M., Lambert D.G. Cellular actions of nociceptin: transduction mechanisms. Peptides 2000, 21:961-967.
8. Holdridge S.V., Cahill C.M. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur. J. Pain 2007, 11:685-693.
9. Hu E., Calò G., Guerrini R., Ko M.C. Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112. Pain 2010, 148:107-113.
10. + (GIRK) channel. Mol. Brain Res. 1997, 45:117-126.
11. Jhamandas K.H., Sutak M., Henderson G. Antinociceptive and modulatory actions of spinal orphanin FQ. Can. J. Physiol. Pharmacol. 1998, 76:314-324.
12. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363.
13. Ko M.C., Naughton N.N. Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys. J. Pain 2009, 10:509-516.
14. Ko M.C., Wei H., Woods J.H., Kennedy R.T. Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies. J. Pharmacol. Exp. Ther. 2006, 318:1257-1264.
15. Lambert D.G. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat. Rev. Drug Discov. 2008, 7:694-710.
16. Luo C., Kumamoto E., Furue H., Chen J., Yoshimura M. Nociceptin inhibits excitatory but not inhibitory transmission to substantia gelatinosa neurones of adult rat spinal cord. Neuroscience 2002, 109:349-358.
17. Marchand F., Ardid D., Chapuy E., Alloui A., Jourdan D., Eschalier A. Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J. Pharmacol. Exp. Ther. 2003, 307:268-274.
18. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Constatntin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 377:532-535.
19. Obara I., Parkitna J.R., Korostynski M., Makuch W., Kaminska D., Przewlocka B., Przewlocki R. Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 2009, 141:283-291.
20. Porreca F., Tang Q.B., Bian D., Riedl M., Elde R., Lai J. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res. 1998, 795:197-203.
21. Reinscheid R.L., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270:792-794.
22. Sotgiu M.L., Bellomi P., Biella G.E. Efficacy of nociceptin inhibition on WDR neuron activity is enhanced in mononeuropathic rats. Brain Res. 2004, 998:251-254.
23. Stanfa L.C., Chapman V., Kerr N., Dickenson A.H. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo. Br. J. Pharmacol. 1996, 118:1875-1877.
24. Stevens C.W., Martin K.K., Stahlheber B.W. Nociceptin produces antinociception after spinal administration in amphibians. Pharmacol. Biochem. Behav. 2009, 91:436-440.
25. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 1976, 17:1031-1036.
26. Yamamoto T., Nozaki-Taguchi N. Effects of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, and N-methyl-D-aspartate receptor antagonists on the thermal hyperalgesia induced by partial sciatic nerve injury in the rat. Anesthesiology 1997, 87:1145-1152.
27. Yamamoto T., Nozaki-Taguchi N., Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience 1997, 81:249-254.
28. Yoon M.H., Choi J.I., Jeong S.W. Antinociception of intrathecal cholinesterase inhibitors and cholinergic receptors in rats. Acta Anaesthesiol. Scand. 2003, 47:1079-1084.
29. Yu L.C., Lu J.T., Huang Y.H., Meuser T., Pietruck C., Gabriel A., Grond S., Palmer P.P. Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats. Brain Res. 2002, 945:88-96.
30. Yu S.Q., Lundeberg T., Yu L.C. Involvement of oxytocin in spinal antinociception in rats with inflammation. Brain Res. 2003, 983:13-22.
31. Zeilhofer H.U., Calò G. Nociceptin/orphanin FQ and its receptor - potential targets for pain therapy. J. Pharmacol. Exp. Ther. 2003, 306:423-429.
32. Zhang X., Bao L., Shi T.J., Ju G., Elde R., Hökfelt T. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 1998, 82:223-240.
33. Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 2001, 429:23-37.